Publish in this journal
Journal Information
Vol. 51. Num. 12.December 2015
Pages e57-e60Pages 611-666
Vol. 51. Num. 12.December 2015
Pages e57-e60Pages 611-666
Letter to the Editor
DOI: 10.1016/j.arbr.2015.10.004
Full text access
Immune-mediated Leukopenia due to Chlamydophila pneumoniae Pneumonia
Leucopenia inmunomediada secundaria a neumonía por Chlamydophila pneumoniae
Cristina Rosario Martína, Blanca Navarro Cubellsb, Francisco Carrión Valeroa,
Corresponding author

Corresponding author.
a Servicio de Neumología, Hospital Clínico Universitario, Valencia, Spain
b Servicio de Hematología, Hospital Clínico Universitario, Valencia, Spain
This item has received
Article information
Full Text
Download PDF
Figures (1)
To the Editor,
Full Text

Chlamydophila pneumoniae is known to affect the immune response of hosts, but this bacteria has not been described as a cause of autoimmune leukopenia. To our knowledge, this is the first report of a patient with C. pneumoniae pneumonia who developed antineutrophil IgG antibodies.

A 37-year-old woman presented with a 1-week history of cough, bloody sputum and fever. Physical examination showed temperature of 38°C and crackles in right lung field. Chest X-ray showed bilateral alveolar infiltrates, corresponding with computed tomography findings of right lower lobe consolidation, and ground glass opacities in left upper lobe and both lower lobes (Fig. 1). ECG was normal. Arterial blood gases: pH: 7.52, PaCO2 34mmHg, PaO2 67mmHg. Clinical laboratory tests: blood glucose 95mg/dl, urea 18mg/dl, creatinine 0.77mg/dl, sodium 139mmol/l, potassium 2.8mmol/l, chloride 98mmol/l, GOT 44U/l, GPT 44U/l, LDH 510U/l, C-reactive protein 287mg/l, procalcitonin 0.18ng/ml, leukocytes 3080μl, neutrophils (76.7%), hemoglobin 10.1g/dl, platelets 222,000μl. Quick time 68%. Microbiology: sputum, blood culture, and pneumococcal and Legionella urinary antigen tests negative. C. pneumoniae serology was positive in acute-phase serum, with elevated antibody titer with seroconversion (17/4/2013 IgG negative [0.157], IgM negative [0.307]; 2/5/2013 IgG indeterminate [0.992], IgM positive [1.428]) on micro-immunofluorescence. During hospitalization, leukopenia worsened to 1770/μl with neutrophil count of 850/μl in the presence of IgG-positive antineutrophil antibodies. Antineutrophil antibodies were detected with fluorescence-labeled polyclonal rabbit anti-human IgM and IgG antibodies (fluorescein isothiocyanate [FITC]) (DAKO). Cell suspension was analyzed using flow cytometry (FACS®, Becton Dickinson). The patient received levofloxacin for 3 weeks, resulting in radiological resolution of the pneumonia and normalization of blood panels.

Fig. 1.

Chest computed tomography showing right lower lobe consolidation.

C. pneumoniae is a Gram-negative bacteria, previously known as Taiwan acute respiratory agent (TWAR). It causes 10% of community-acquired pneumonias (CAP) in Europe (12% of CAPs that do not require hospitalization and 3% of those that do).1,2 It may be responsible for immunological phenomena related to coronary arteriosclerosis,3 but it is unusual for it to cause autoimmune leukopenia associated with antineutrophil IgG antibodies, as occurred in our case.

In autoimmune neutropenia, antibodies develop that act directly against cell membrane antigens, causing peripheral destruction of neutrophils. These antineutrophil antibodies promote phagocytosis of neutrophils opsonized by splenic macrophages.4 Autoimmune neutropenia may be primary or secondary and is more common in adults. It is often related to autoimmune diseases (primary biliary cirrhosis, Sjögren syndrome, lupus erythematosus, and rheumatoid arthritis), as well as to exposure to medication (fludarabine, rituximab), solid tumors and blood cancers, neurological diseases, such as multiple sclerosis, or infections. Viral infections, such as human immunodeficiency virus, es Parvovirus¸ or Epstein–Barr virus, bacteria, such as Helicobacter pylori, Escherichia coli, Neisseria meningitidis, Brucella ssp., Salmonella spp. and Mycobacterium tuberculosis, and other pathogens, including Toxoplasma gondii, Leishmania spp. and malaria, have also been implicated. However, a review of the literature did not yield any report of autoimmune neutropenia developing as a result of C. pneumoniae infection.5

R. Cosentini, F. Blasi, R. Raccanelli, S. Rossi, C. Arosio, P. Tarsia
Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae
Respiration, 63 (1996), pp. 61-65
R. Menéndez, A. Torres, J. Aspa, A. Capelastegui, C. Prat, F. Rodríguez de Castro
Normativa SEPAR. Neumonía adquirida en la comunidad
Arch Bronconeumol, 46 (2010), pp. 543-558
E. Linnanmäki, M. Leinonen, K. Mattila, M.S. Nieminen, V. Valtonen, P. Saiikku
Chlamydia pneumonia-specific circulating immune complexes in patients with chronic coronary heart diseases
Circulation, 87 (1993), pp. 1130-1134
P. Vergara Moscoso
Patogenia de las citopenias autoinmunes primarias
Rev Chil Reumatol, 25 (2009), pp. 26-36
F. Capsoni, P. Sarzi-Puttini, A. Zanella
Primary and secondary autoimmune neutropenia
Arthritis Res Ther, 7 (2005), pp. 208-214

Please cite this article as: Rosario Martín C, Navarro Cubells B, Carrión Valero F. Leucopenia inmunomediada secundaria a neumonía por Chlamidophila pneumoniae. Arch Bronconeumol. 2015;51:663–664.

Copyright © 2014. SEPAR
Archivos de Bronconeumología (English Edition)

Subscribe to our Newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.